World Orphan Drug Congress USA focusses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster.
Walter Colasante, Vice President in the Life Sciences Practice, will be speaking on “Value assessment is different for Rare Diseases, requiring new thinking to build consensus around access decisions” and Charles River Associates is a silver sponsor at this year’s conference.
For more information on this event, click here.
Access solutions: Reconciling potential for improved patient access with implementation realities
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...